14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TSRO
Delisted

TESARO Fund Price (Quote)

$74.96
+0 (+0%)
At Close: Feb 13, 2019

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 13th Feb 2019 TSRO stock ended at $74.96. During the day the stock fluctuated 0% from a day low at $74.96 to a day high of $74.96.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TESARO prices

Date Open High Low Close Volume
Apr 27, 2018 $52.19 $53.21 $51.59 $52.56 533 887
Apr 26, 2018 $51.80 $53.22 $51.21 $52.11 510 088
Apr 25, 2018 $53.18 $54.35 $51.47 $51.78 1 244 251
Apr 24, 2018 $52.49 $53.82 $52.08 $53.02 901 933
Apr 23, 2018 $51.60 $52.64 $51.40 $51.98 457 496
Apr 20, 2018 $52.33 $53.07 $51.25 $51.58 641 252
Apr 19, 2018 $54.29 $55.06 $52.00 $52.21 909 965
Apr 18, 2018 $55.29 $56.31 $54.46 $54.53 545 055
Apr 17, 2018 $56.27 $59.93 $54.34 $54.91 1 352 878
Apr 16, 2018 $52.57 $57.99 $51.41 $55.51 1 596 860
Apr 13, 2018 $54.71 $55.33 $52.00 $52.26 877 503
Apr 12, 2018 $55.75 $56.49 $52.56 $54.20 918 172
Apr 11, 2018 $53.45 $56.61 $51.81 $55.70 861 148
Apr 10, 2018 $52.31 $54.20 $51.33 $53.54 1 043 915
Apr 09, 2018 $54.99 $55.70 $50.67 $51.78 2 058 197
Apr 06, 2018 $56.18 $59.94 $53.50 $54.70 1 500 111
Apr 05, 2018 $57.50 $57.97 $55.65 $56.46 634 521
Apr 04, 2018 $54.74 $57.55 $54.23 $57.19 603 922
Apr 03, 2018 $56.06 $56.74 $53.87 $55.44 592 731
Apr 02, 2018 $56.40 $57.87 $53.34 $55.45 1 098 961
Mar 29, 2018 $58.89 $59.78 $56.95 $57.14 760 597
Mar 28, 2018 $56.98 $59.53 $55.76 $58.42 850 472
Mar 27, 2018 $60.44 $61.45 $56.29 $56.70 889 446
Mar 26, 2018 $61.25 $63.75 $55.77 $59.03 1 336 294
Mar 23, 2018 $60.75 $63.23 $59.51 $60.38 699 195
Click to get the best stock tips daily for free!

About TESARO

TESARO, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States and internationally. Its product portfolio consist of Rolapitant, a neurokinin-1 receptor antagonist, which is in phase 1 intravenous clinical trials for the prevention of chemotherapy induced nausea and vomiting; Niraparib, an orally active and potent poly p... TSRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT